Eisai Co. | Eisai | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Eisai Inc. | Eisai | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,658,249 |
Eisai Company | Eisai | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
EISAI INC. | Eisai | workplace safety or health violation | 2010 | OSHA | $6,376 |
Dr. Reddy's Laboratories Inc. | Dr. Reddy's Laboratories | drug or medical equipment safety violation | 2018 | DOJ_CIVIL | $5,000,000 |
Dr. Reddy's Laboratories | Dr. Reddy's Laboratories | False Claims Act and related | 2022 | TX-AG | $12,900,000 |
Dr. Reddy's Laboratories Ltd. | Dr. Reddy's Laboratories | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $400,000 |
Daiichi Sankyo Inc. | Daiichi Sankyo | False Claims Act and related | 2015 | DOJ_CIVIL | $39,000,000 |
Daiichi Sankyo | Daiichi Sankyo | employment discrimination | 2016 | private lawsuit-federal | $8,200,000 |
Daiichi Pharmaceutical | Daiichi Sankyo | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $4,340,100 |
Daiichi Pharmaceutical | Daiichi Sankyo | price-fixing or anti-competitive practices | 2000 | CA-AG | $1,446,700 |
Daiichi Pharmaceutical | Daiichi Sankyo | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Daiichi Sankyo, Inc. | Daiichi Sankyo | False Claims Act and related | 2015 | MULTI-AG | $39,000,000 |
Daiichi Sankyo Inc. | Daiichi Sankyo | product safety violation | 2017 | private lawsuit-federal | $300,000,000 |
Daiichi Pharmaceutical | Daiichi Sankyo | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
Cytrx Corporation | CytRx | investor protection violation | 2017 | SEC | $75,000 |
Cypress Pharmaceutical Inc. | Currax Pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $2,800,000 |
PERNIX THERAPEUTICS, LLC | Currax Pharmaceuticals | benefit plan administrator violation | 2019 | EBSA | $10,001 |
Pernix Therapeutics | Currax Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $800,000 |
Pernix Therapeutics, LLC | Currax Pharmaceuticals | WARN Act violation | 2019 | private lawsuit-federal | $300,000 |
AMRI Rensselaer, Inc. | Curia Inc. | environmental violation | 2018 | NY-ENV | $21,250 |
AMRI Rensselaer, Inc. | Curia Inc. | environmental violation | 2014 | NY-ENV | $45,000 |
CSL Behring, LLC | CSL Limited | environmental violation | 2021 | EPA | $527,144 |
CSL Plasma Inc. | CSL Limited | privacy violation | 2022 | private lawsuit-federal | $9,900,000 |
CSL Limited | CSL Limited | price-fixing or anti-competitive practices | 2014 | private lawsuit-federal | $64,000,000 |
ZLB Behring, L.L.C. | CSL Limited | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
CSL PLASMA | CSL Limited | workplace safety or health violation | 2019 | OSHA | $15,422 |
CSL Behring LLC | CSL Limited | environmental violation | 2015 | EPA | $62,780 |
CSL BEHRING LLC | CSL Limited | environmental violation | 2021 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $527,144 |
Clovis Oncology Inc. | Clovis Oncology | investor protection violation | 2018 | SEC | $20,000,000 |
CAMBREX CHARLES CITY, INC. | Cambrex | workplace safety or health violation | 2007 | OSHA | $6,375 |
CAMBREX CHARLES CITY, INC. | Cambrex | workplace safety or health violation | 2018 | OSHA | $18,000 |
CAMBREX CHARLES CITY, INC | Cambrex | environmental violation | 2006 | EPA | $106,749 |
Bristol-Myers Squibb | Bristol-Myers Squibb | Foreign Corrupt Practices Act | 2015 | SEC | $14,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2009 | FTC | $2,100,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | drug or medical equipment safety violation | 2007 | DOJ_ANTITRUST | $1,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | off-label or unapproved promotion of medical products | 2007 | DOJ_CIVIL | $515,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | environmental violation | 2008 | EPA | $3,650,000 |
DuPont Pharmaceuticals Company | Bristol-Myers Squibb | economic sanction violation | 2004 | OFAC | $6,600 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | accounting fraud or deficiencies | 2004 | SEC | $150,000,000 |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | wage and hour violation | 2004 | WHD | $160,203 |
Bristol-Myers Squibb Medical Imaging, Inc. | Bristol-Myers Squibb | export control violation | 2004 | BIS | $16,200 |
Celgene Corp. | Bristol-Myers Squibb | False Claims Act and related | 2017 | USAO | $280,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | fraud | 2005 | USAO | $300,000,000 |
Briston-Myers Squibb | Bristol-Myers Squibb | benefit plan administrator violation | 2005 | private lawsuit-federal | $41,220,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $187,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | off-label or unapproved promotion of medical products | 2016 | MULTI-AG | $19,500,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $55,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2008 | AL-AG | $11,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2010 | PA-AG | $27,600,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $100,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $1,100,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | consumer protection violation | 2019 | WV-AG | $1,600,000 |
Bristol-Myers Squibb Company and Apothecon, Inc. | Bristol-Myers Squibb | False Claims Act and related | 2008 | ID-AG | $1,738,719 |
Celgene Corp. | Bristol-Myers Squibb | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,700,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | kickbacks and bribery | 2016 | CA-INS | $30,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | environmental violation | 2011 | CT-ENV | $20,000 |
E R SQUIBB & SONS LLC | Bristol-Myers Squibb | environmental violation | 2013 | NJ-ENV | $5,950 |
E.R. SQUIBB & SONS | Bristol-Myers Squibb | environmental violation | 2009 | NJ-ENV | $10,000 |
BRISTOL MYERS SQUIBB CO | Bristol-Myers Squibb | environmental violation | 2005 | NJ-ENV | $12,000 |
BRISTOL-MYERS SQUIBB CO | Bristol-Myers Squibb | environmental violation | 2003 | NJ-ENV | $28,000 |
BRISTOL-MYERS SQUIBB CO | Bristol-Myers Squibb | environmental violation | 2001 | NJ-ENV | $6,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2021 | USAO | $75,000,000 |
Bristol Myers Squibb Co. | Bristol-Myers Squibb | False Claims Act and related | 2021 | MULTI-AG | $75,000,000 |
Abraxis Bioscience, Inc. | Bristol-Myers Squibb | environmental violation | 2012 | CA-SCAQMD | $5,000 |
American BioScience Inc. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $815,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $50,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $65,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,800,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,000,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $19,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $220,000,000 |
Celgene Corporation | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $34,000,000 |
DuPont Pharmaceuticals Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2002 | private lawsuit-federal | $44,500,000 |
BRISTOL-MYERS SQUIBB | Bristol-Myers Squibb | environmental violation | 2023 | MA-ENV | $11,615 |
BRISTOL - MYERS SQUIBB MEDICAL IMAGING INC | Bristol-Myers Squibb | environmental violation | 2009 | EPA | $19,538 |
Bristol-Myers Squibb | Bristol-Myers Squibb | environmental violation | 2009 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,328,154 |
Bristol Myers Squibb Company | Bristol-Myers Squibb | environmental violation | 2008 | EPA | $66,770 |
Bristol Myers Squibb Manufacturing Company | Bristol-Myers Squibb | environmental violation | 2008 | EPA | $52,000 |
E.R. Squibb & Sons LLC | Bristol-Myers Squibb | environmental violation | 2009 | EPA | $8,125 |
Celgene Corporation | Bristol-Myers Squibb | environmental violation | 2013 | EPA | $6,035 |
BRISTOL-MYERS SQUIBB COMPANY | Bristol-Myers Squibb | environmental violation | 2000 | EPA | $5,000 |
Boehringer Ingelheim Pharmaceuticals Inc. | Boehringer Ingelheim | off-label or unapproved promotion of medical products | 2012 | FDA | $95,000,000 |
Boehringer Ingelheim Pharmaceutical, Inc. | Boehringer Ingelheim | labor relations violation | 2004 | NLRB | $50,000 |
BOEHRINGER INGELHEIM PHARMACEUTICALS | Boehringer Ingelheim | aviation safety violation | 2014 | FAA | $15,000 |
Boehringer Ingelheim | Boehringer Ingelheim | False Claims Act and related | 2012 | LA-AG | $3,250,000 |
Boehringer Ingelheim Corp. | Boehringer Ingelheim | False Claims Act and related | 2005 | TX-AG | $10,000,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | $13,500,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | False Claims Act and related | 2010 | WI-AG | $7,750,000 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc. | Boehringer Ingelheim | False Claims Act and related | 2009 | KY-AG | $4,500,000 |
Boehringer Ingleheim | Boehringer Ingelheim | False Claims Act and related | 2011 | KS-AG | $1,400,000 |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $95,000,000 |
Boehringer Ingelheim Animal Health USA Inc. | Boehringer Ingelheim | employment discrimination | 2020 | OFCCP | $379,089 |
Boehringer Ingelheim International | Boehringer Ingelheim | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $650,000,000 |
Boehringer Ingelheim Pharma GmbH | Boehringer Ingelheim | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $27,000,000 |
Boehringer Ingelheim Pharma GmbH | Boehringer Ingelheim | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $73,000,000 |
Biogen Idec, Inc. | Biogen | wage and hour violation | 2009 | WHD | $49,600 |
Biogen Idec Inc. | Biogen | wage and hour violation | 2005 | WHD | $6,934 |
Biogen Idec Inc. | Biogen | consumer protection violation | 2007 | VT-AG | $10,000 |
Biogen, Inc. | Biogen | False Claims Act and related | 2020 | DOJ_CIVIL | $22,000,000 |
Biogen Inc. | Biogen | False Claims Act and related | 2022 | DOJ_CIVIL | $900,000,000 |